Botanical extracts power new products from P&G Health and Théa Pharmaceuticals in the areas of pain and eye-care respectively, while TheOTCLab and Stada relaunch much-loved foot care and cold brands in this German OTC marketing update.
Back pain is a problem for many Germans, Procter & Gamble points out in the press release for its latest launch. “There are many ways to relieve pain. In addition to painkillers, more and more sufferers are looking for a natural alternatives.”
To address this need, P&G Health has through its German Wick division launched the Kytta pain ointment, which uses comfrey...
Create an account to read this article
Already a subscriber?
The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.
Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”
Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.
Gum health awareness among British consumers could be better, a recent Haleon survey finds.
Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.
Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.
Meet UK women's health start-up GP Nutrition, run by busy working mother of four Gabriela Peacock, who says she "truly understands the needs of the women who are looking to her for help.”
